Literature DB >> 21255901

The history and usage of the vaginal pessary: a review.

Reeba Oliver1, Ranee Thakar, Abdul H Sultan.   

Abstract

It is expected that with the rising female life expectancy the prevalence of pelvic organ prolapse will increase. From ancient times mechanical devices have been used to reposition prolapsed organs. Given that surgical correction of prolapse is associated with high recurrence rates, pessaries offer a favorable alternative. In spite of the antiquity of pessary usage the evidence for its use, the effectiveness of symptom relief, and the nuances of clinical management with the pessary in situ have not been studied methodically. There is a need for controlled trials to assess the efficacy of pessaries as opposed to other non-surgical and surgical methods of treating pelvic organ prolapse. Additionally, the long term effects and complications of pessary usage have not been assessed in trials, and knowledge about the potential complications caused by the pessary rests mainly on anecdotal data. This review provides a historical perspective and appraises the current knowledge regarding the indications, effectiveness and the potential complications associated with pessary use. Data were obtained from an electronic search of Medline (1966-2010) and by hand searching the citations which were not available online. Keywords used were pelvic organ prolapse, pelvic floor dysfunction, vaginal pessary and urinary incontinence. Textbooks are also quoted where relevant. Most studies report moderate success rates in the short term following insertion of a pessary for the management of prolapse and concur in the remission of almost all symptoms attributable to the prolapse. Reported success is variable in the remission of urinary and bowel symptoms. We conclude that based on the available evidence (mostly retrospective and prospective cohort studies), treatment with a vaginal pessary is a feasible option that can be offered in the short term to women with prolapse. There is a need for controlled trials to assess the long term efficacy.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21255901     DOI: 10.1016/j.ejogrb.2010.12.039

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  20 in total

Review 1.  An integrative review and severity classification of complications related to pessary use in the treatment of female pelvic organ prolapse.

Authors:  Marwa Abdulaziz; Lynn Stothers; Darren Lazare; Andrew Macnab
Journal:  Can Urol Assoc J       Date:  2015 May-Jun       Impact factor: 1.862

2.  Delayed vesicovaginal fistula after ring pessary usage.

Authors:  Katherine Jane Penrose; Jessica Ma Yin; Nicolas Tsokos
Journal:  Int Urogynecol J       Date:  2013-06-26       Impact factor: 2.894

3.  Diagnosis and Therapy of Female Pelvic Organ Prolapse. Guideline of the DGGG, SGGG and OEGGG (S2e-Level, AWMF Registry Number 015/006, April 2016).

Authors:  K Baeßler; T Aigmüller; S Albrich; C Anthuber; D Finas; T Fink; C Fünfgeld; B Gabriel; U Henscher; F H Hetzer; M Hübner; B Junginger; K Jundt; S Kropshofer; A Kuhn; L Logé; G Nauman; U Peschers; T Pfiffer; O Schwandner; A Strauss; R Tunn; V Viereck
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-12       Impact factor: 2.915

4.  Vaginal pessaries in the management of symptomatic pelvic organ prolapse in rural Kilimanjaro, Tanzania: a pre-post interventional study.

Authors:  Benjamin C Shayo; Gileard G Masenga; Vibeke Rasch
Journal:  Int Urogynecol J       Date:  2018-08-18       Impact factor: 2.894

5.  Surgical interventions for uterine prolapse and for vault prolapse: the two VUE RCTs.

Authors:  Christine Hemming; Lynda Constable; Beatriz Goulao; Mary Kilonzo; Dwayne Boyers; Andrew Elders; Kevin Cooper; Anthony Smith; Robert Freeman; Suzanne Breeman; Alison McDonald; Suzanne Hagen; Isobel Montgomery; John Norrie; Cathryn Glazener
Journal:  Health Technol Assess       Date:  2020-03       Impact factor: 4.014

Review 6.  Pessaries (mechanical devices) for pelvic organ prolapse in women.

Authors:  Carol Bugge; Elisabeth J Adams; Deepa Gopinath; Fiona Reid
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

7.  An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the conservative and nonpharmacological management of female pelvic floor dysfunction.

Authors:  Kari Bo; Helena C Frawley; Bernard T Haylen; Yoram Abramov; Fernando G Almeida; Bary Berghmans; Maria Bortolini; Chantale Dumoulin; Mario Gomes; Doreen McClurg; Jane Meijlink; Elizabeth Shelly; Emanuel Trabuco; Carolina Walker; Amanda Wells
Journal:  Int Urogynecol J       Date:  2016-12-05       Impact factor: 2.894

8.  Effect of vaginal estrogen on pessary use.

Authors:  Sybil G Dessie; Katherine Armstrong; Anna M Modest; Michele R Hacker; Lekha S Hota
Journal:  Int Urogynecol J       Date:  2016-03-18       Impact factor: 2.894

9.  How often should shelf/Gellhorn pessaries be changed? A survey of IUGA urogynaecologists.

Authors:  A Khaja; R M Freeman
Journal:  Int Urogynecol J       Date:  2014-02-15       Impact factor: 2.894

10.  The cube pessary: an underestimated treatment option for pelvic organ prolapse? Subjective 1-year outcomes.

Authors:  Zoltan Nemeth; Sándor Nagy; Johannes Ott
Journal:  Int Urogynecol J       Date:  2013-04-12       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.